Medicare Part D Cost Sharing Cannot Exceed Net Price In House PBM, Transparency Bill

The legislation’s pharmacy benefit manager-related provisions emphasize reporting over more direct reforms, which is similar to other PBM transparency bills circulating in Congress.

The Ways and Means Committee moved Relatively Modest PBM Oversight Legislation. • Source: Shutterstock

Medicare Part D beneficiaries cannot be subject to cost sharing greater than the net cost of a drug after rebates under legislation passed by the House Ways and Means Committee during a markup 26 July.

Key Takeaways

  • House Ways and Means Committee bill’s cost-sharing protections would begin in Medicare Part D in 2027.

The cost sharing protection would begin “on or after” 1 January 2027 and apply to beneficiaries who have met their...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Market Access

More from Pink Sheet